Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,042 public trials 1,178 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy

NCT04015245

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: ChiMei Medical Center Tainan, Taiwan

View Trial Details

Completed

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

NCT00941967

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France

View Trial Details

Completed

Hepatocellular Carcinoma Registry for Turkey (3K Trial)

NCT01473121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Multiple Locations, Turkey (Türkiye)

View Trial Details

Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations: Emory University, Winship Cancer Institute Atlanta, Georgia, United States

Investigational Drug Service Atlanta, Georgia, United States

The Emory Clinic Atlanta, Georgia, United States

Loyola University Medical Center Maywood, Illinois, United States

View all 113 locations

View Trial Details

Completed

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

NCT01026337

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors

NCT01603004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

NCT01206764

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Novartis Investigative Site Algiers, Algeria

Novartis Investigative Site Oran, Algeria

Novartis Investigative Site Al Mansurah, Egypt

Novartis Investigative Site Alexandria, Egypt

View all 22 locations

View Trial Details

Completed

Fingerprint Characterization of Advanced HCC

NCT02372162

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: University Hospital Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Completed

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

NCT00923897

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer

NCT02370277

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +17 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions